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Abstract
Background  and  objectives:  Intraoperative  use  of  opioids  may  be  associated  with  postoperative
hyperalgesia  and  increased  analgesic  consumption.  Side  effects  due  to  perioperative  use  of
opioids, such  as  postoperative  nausea  and  vomiting  may  delay  discharge.  We  hypothesized
that total  intravenous  anesthesia  consisting  of  lidocaine  and  dexmedetomidine  as  an  opioid
substitute  may  be  an  alternative  technique  for  laparoscopic  cholecystectomy  and  would  be
associated  with  lower  fentanyl  requirements  in  the  postoperative  period  and  less  incidence  of
postoperative  nausea  and  vomiting.
Methods:  80  Anesthesiologists  I--II  adults  were  scheduled  for  elective  laparoscopic  cholecystec-
tomy. Patients  were  randomly  allocated  into  two  groups  to  have  either  opioid-free  anesthesia
with dexmedetomidine,  lidocaine,  and  propofol  infusions  (Group  DL)  or  opioid-based  anesthesia
with remifentanil,  and  propofol  infusions  (Group  RF).  All  patients  received  a  standard  multi-
modal analgesia  regimen.  A  patient  controlled  analgesia  device  was  set  to  deliver  IV  fentanyl
for 6  h  after  surgery.  The  primary  outcome  variable  was  postoperative  fentanyl  consumption.
Results: Fentanyl  consumption  at  postoperative  2nd  hour  was  statistically  signiﬁcantly  less  in
Group DL,  compared  with  Group  RF,  which  were  75  ±  59  g  and  120  ±  94  g  respectively,  whileperative  6th  hour.  During  anesthesia,  there  were  more  hypotensive
here  were  more  hypertensive  events  in  Group  DL,  which  were  both
spite  higher  recovery  times,  Group  DL  had  signiﬁcantly  lower  pain
d  ondansetron  need.it was  comparable  at  posto
events in  Group  RF,  while  t
statistically  signiﬁcant.  De
scores, rescue  analgesic  an Trial registration: Clinicaltrials.gov (ID: NCT01833819).
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Conclusion:  Opioid-free  anesthesia  with  dexmedetomidine,  lidocaine  and  propofol  infusions
may be  an  alternative  technique  for  laparoscopic  cholecystectomy  especially  in  patients  with
high risk  for  postoperative  nausea  and  vomiting.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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Anestesia  venosa  total  livre  de  opioides,  com  infusões  de  propofol,  dexmedetomidina
e  lidocaína  para  colecistectomia  laparoscópica:  estudo  prospectivo,  randomizado  e
duplo-cego
Resumo
Justiﬁcativa  e  objetivos:  O  uso  de  opioides  no  período  intraoperatório  pode  estar  associado
à hiperalgesia  e  ao  aumento  do  consumo  de  analgésicos  no  período  pós-operatório.  Efeitos
colaterais  como  náusea  e  vômito  no  período  pós-operatório,  por  causa  do  uso  perioperatório
de opioides,  podem  prolongar  a  alta.  Nossa  hipótese  foi  que  a  anestesia  venosa  total  com  o
uso de  lidocaína  e  dexmedetomidina  em  substituic¸ão  a  opioides  pode  ser  uma  técnica  opcional
para a  colecistectomia  laparoscópica  e  estaria  associada  a  uma  menor  solicitac¸ão  de  fentanil  e
incidência de  náusea  e  vômito  no  período  pós-operatório.
Métodos:  Foram  programados  para  colecistectomia  laparoscópica  eletiva  80  pacientes  adultos,
estado físico  ASA  I-II.  Os  pacientes  foram  randomicamente  alocados  em  dois  grupos  para  rece-
ber anestesia  livre  de  opioides  com  infusões  intravenosas  (IV)  de  dexmedetomidina,  lidocaína  e
propofol (Grupo  DL)  ou  anestesia  baseada  em  opioides  com  infusões  de  remifentanil  e  propofol
(Grupo RF).  Todos  os  pacientes  receberam  um  regime  padrão  de  analgesia  multimodal.  Um  dis-
positivo de  analgesia  controlada  pelo  paciente  foi  ajustado  para  liberar  fentanil  IV  por  seis  horas
após a  cirurgia.  O  desfecho  primário  foi  o  consumo  de  fentanil  no  pós-operatório.
Resultados:  O  consumo  de  fentanil  na  segunda  hora  de  pós-operatório  foi  signiﬁcativamente
menor no  grupo  DL  do  que  no  Grupo  RF,  75  ±  59  g  e  120  ±  94  g,  respectivamente,  mas  foi  com-
parável na  sexta  hora  de  pós-operatório.  Durante  a  anestesia,  houve  mais  eventos  hipotensivos
no Grupo  RF  e  mais  eventos  hipertensivos  no  grupo  DL,  ambos  estatisticamente  signiﬁcativos.
Apesar de  apresentar  um  tempo  de  recuperac¸ão  mais  prolongado,  o  Grupo  DL  apresentou
escores de  dor  e  consumo  de  analgésicos  de  resgate  e  de  ondansetrona  signiﬁcativamente  mais
baixos.
Conclusão:  A  anestesia  livre  de  opioides  com  infusões  de  dexmedetomidina,  lidocaína  e  propo-
fol pode  ser  uma  técnica  opcional  para  a  colecistectomia  laparoscópica,  especialmente  em
pacientes  com  alto  risco  de  náusea  e  vômito  no  pós-operatório.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
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ntroduction
pioids  are  widely  used  for  perioperative  analgesia.  How-
ver,  the  intraoperative  use  of  large  bolus  doses  or
ontinuous  infusions  of  potent  opioids  may  be  associated
ith  postoperative  hyperalgesia  and  increased  analgesic
onsumption.1 When  it  comes  to  ambulatory  surgery,  opioid
elated  side  effects,  such  as  postoperative  nausea  and  vomi-
ing  (PONV),  prolonged  sedation,  ileus  and  urinary  retention
ay  delay  recovery  and  discharge  or  cause  unanticipated
ospital  readmission.
The  postoperative  pain  after  laparoscopic  cholecystec-
omy  (LC)  is  complex  in  nature  and  growing  evidence
uggests  that  its  treatment  should  be  multimodal  and  opi-
2,3id  sparing  to  accelerate  recovery. In  spite  of  multimodal
nalgesic  strategies,  which  consist  of  opioids,  dexameth-
sone,  non-steroidal  anti-inﬂammatory  drugs,  and  local
nesthetics  applied  into  the  surgical  wound,  postoperative
h
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pain  and  PONV  are  still  common  complaints  reported  after
C.  It  has  been  suggested  that  esmolol  infusion  may  be  an
cceptable  alternative  to  remifentanil  infusion  for  ambu-
atory  laparoscopic  surgery4--6 and  opioid-free  anesthetic
echniques  with  esmolol  infusion  is  associated  with  reduced
ostoperative  opioid  consumption.5,6
Dexmedetomidine  is  a highly  selective  alfa-2  adreno-
eptor  agonist  that  provides  sedation,  analgesia,  and  sym-
atholysis.  Although  perioperative  intravenous  dexmedeto-
idine  administration  is  associated  with  a  reduction  in
ostoperative  pain  intensity,  analgesic  consumption  and
ausea,7--12 the  analgesic  property  of  dexmedetomidine  is
ess  effective  compared  with  remifentanil.13 Intravenous
idocaine  has  been  described  as  having  analgesic,  anti-
yperalgesic,  and  anti-inﬂammatory  properties.  Intravenous
idocaine  infusion  in  the  perioperative  period  is  safe
nd  has  clear  advantages,  such  as  decreased  intraopera-
ive  anesthetic  requirements,  lower  pain  scores,  reduced
ostoperative  analgesic  requirements,  as  well  as  faster
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return  of  bowel  function  and  decreased  length  of  hospital
stay.14--20 Therefore,  we  hypothesize  that  total  intravenous
anesthesia  (TIVA)  consisting  of  lidocaine  combined  with
dexmedetomidine  as  an  opioid  substitute  is  a  feasible  tech-
nique  for  LC  and  would  be  associated  with  lower  fentanyl
requirements  in  the  early  postoperative  period  and  less  inci-
dence  of  PONV.
The  present  prospective,  randomized,  double-blinded
study  was  designed  to  compare  the  effect  of  opioid-
free  (using  dexmedetomidine,  lidocaine  and  propofol
infusions)  and  opioid-based  (using  remifentanil  and  propofol
infusions)  TIVA  techniques  on  postoperative  pain  intensity
and  the  incidence  of  side  effects  in  patients  scheduled
for  LC.
Methods
After  obtaining  the  Ethics  Committee’s  approval  and
the  patients’  written  informed  consent,  the  study  was
conducted  between  June  2012  and  April  2013  at  our  univer-
sity  hospital.  Patients  scheduled  for  elective  laparoscopic
cholecystectomy,  who  had  the  American  Society  of  Anesthe-
siologists  (ASA)  I  or  II  physical  status,  and  were  20--60  years
of  age  were  included  in  this  study.  The  exclusion  criteria
were:  a  body  mass  index  >35  kg  m−2,  pregnant,  breast-
feeding  or  menstruating  women,  hepatic,  renal  or  cardiac
insufﬁciency,  diabetes,  history  of  chronic  pain,  alcohol  or
drug  abuse,  psychiatric  disease,  allergy  or  contraindica-
tion  to  any  of  the  study  drugs,  inability  to  comprehend
pain  assessment  and  to  use  a  patient-controlled  analgesia
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Assessed for eligibilit
Analysed (n=40) 
Excluded from analysis (n=0)  
Lost to follow-up (n=0) 
Discontinued intervention (n=2) 
Reasons: converted to open (n=1), unable 
to use PCA (n=1)                      
Allocated to Group RF (n=42) 
- Received allocated intervention (n=42)  
Allocation
Analysis
Follow-up 
Randomized (n
Enrollment 
Figure  1  Flow  of  the  participants  thro193
PCA)  device.  Written  informed  consent  was  obtained  from
atients  before  randomization.
andomization  and  blinding
atients  were  randomly  allocated  into  two  groups  to  have
ither  opioid-free  anesthesia  (Group  DL)  with  dexmedetomi-
ine  (0.6  g  kg−1 loading,  0.3  g  kg−1 h−1 infusion),  lidocaine
1.5  mg  kg−1 loading,  2  mg  kg−1 h−1 infusion),  and  propofol
nfusions  or  opioid-based  anesthesia  (Group  RF)  with  fen-
anyl,  and  remifentanil  (0.25  g  kg−1 min−1),  and  propofol
nfusions  (Fig.  1).
Simple  randomization  was  done  using  80  opaque  sealed
nvelopes,  40  for  each  group,  indicating  group  assignment
nd  describing  the  anesthetic  protocol.  Before  anesthesia
nduction,  an  anesthesiologist  opened  the  next  envelope  in
he  sequence  to  reveal  the  treatment  allocation.  This  anes-
hesiologist  only  prepared  the  study  medications  and  was
ot  involved  in  preoperative  and  postoperative  data  collec-
ion  or  anesthesia  management  of  the  patients.
Time  chart  of  anesthetic  management  is  shown  in  Table  1.
he  drugs  were  delivered  in  10  mL  and  50  mL  syringes
abeled  as  ‘‘loading’’  or  ‘‘infusion’’  respectively.  To  ensure
roper  blinding,  the  loading  doses  of  drugs  (dexmedetomi-
ine  and  lidocaine  in  Group  DL  or  fentanyl  and  normal  saline
n  Group  RF)  were  calculated  according  to  the  patient’s
ody  weight  and  diluted  to  a  10  mL  volume  labeled  as
‘loading-1’’  and  ‘‘loading-2’’  in  order  of  administration.
he  infusion  drugs  (dexmedetomidine  and  lidocaine  in  Group
L  or  remifentanil  and  normal  saline  in  Group  RF)  were
y (n=197) 
Excluded (n=112)
- Not meeting inclusion criteria (n=96)
- Declined to participate (n=16)
Lost to follow-up (n=0) 
Discontinued intervention (n= 3) 
Reasons: converted to open (n=2), unable
to use PCA (n=1)                          
Allocated to Group DL (n=43)  
- Received allocated intervention (n=43) 
Analysed (n=40) 
Excluded from analysis (n=0)
=85) 
ugh  each  stage  of  randomization.
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Table  1  Time  chart  of  anesthetic  management.
Premedication  Loading  (10  min)  Induction  Maintenance
A↓ B↓  C↓  D↓
Group  DL
Midazolam
(0.03  mg  kg−1)
Loading  1:
Dexmedetomidine
(0.6  g  kg−1)
Infusion  1:
Dexmedetomidine
(0.3  g  kg−1 h−1)
(0.3  mL  kg−1)
Loading  2:
Lidocaine
(1.5  mg  kg−1)
Infusion  2:  Lidocaine  (2  mg  kg−1 h−1)  (0.1  mL  kg−1)
Propofol
(1.5 mg  kg−1)
Propofol  (3--12  mg  kg−1 h−1)
Group RF
Midazolam
(0.03  mg  kg−1)
Loading  1:
Fentanyl
(2  g  kg−1)
Infusion  1:  Remifentanil  (0.25  g  kg−1 min−1)  (0.3  mL  kg−1)
Loading 2:  0.9%
Saline
Infusion  2:  0.9%  Saline  infusion  (0.1  mL  kg−1)
Propofol
(1.5 mg  kg−1)
Propofol  (3--12  mg  kg−1 h−1)
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eA, Baseline hemodynamic values recorded; B, Endotracheal intub
of surgery, propofol infusion and ‘Infusion 1’ was stopped.
repared  in  50  mL  syringes  and  labeled  as  ‘‘infusion-1’’  and
‘infusion-2’’  respectively.
nesthetic  technique
t  the  preoperative  holding  area,  patients  were  instructed
n  the  use  of  the  numerical  rating  scale  (NRS)  and  patient
ontrolled  analgesia  (PCA)  pump.  An  anesthesiologist  who
s  blinded  to  the  study  groups  performed  all  procedures.
n  arrival  at  the  operating  room,  standard  monitoring
as  applied  consisting  of  ECG,  non-invasive  blood  pres-
ure,  pulse  oximetry,  temperature,  and  bispectral  index
BIS).  After  premedication  with  intravenous  midazolam
.03  mg  kg−1,  baseline  heart  rate  and  mean  arterial  blood
ressure  (MAP)  were  determined  which  is  the  average
f  three  consecutive  measurements.  Intravenous  bal-
nced  crystalloid  solution  (Isolyte-S)  was  started  and
re-oxygenation  with  5  L  min−1 of  pure  oxygen  was  per-
ormed  during  administration  of  loading  doses.  Before
nduction,  patients  in  Group  DL  received  0.6  g  kg−1
exmedetomidine  (loading-1)  diluted  to  a  total  volume
f  10  mL  and  infused  in  10  min.  To  avoid  bias,  patients  in
roup  RF  received  fentanyl  2  g  kg−1 in  the  same  fashion.  At
he  induction,  dexmedetomidine  or  remifentanil  infusions
in  1 g  mL−1 and  50  g  mL−1 concentrations  respectively,
abeled  as  infusion-1)  at  0.3  mL  kg−1 h−1 were  started.  Lido-
aine  at  1.5  mg  kg−1 (loading-2)  in  Group  DL  or  normal  saline
n  Group  RF  and  propofol  at  1.5  mg  kg−1 was  administered.
idocaine  (20  mg/mL)  or  normal  saline  infusions  (infusion-2)
t  0.1  mL  kg−1 h−1 and  propofol  infusion  at  10  mg  kg−1 h−1
as  started  immediately  after  loading  doses.  Vecuronium
t  0.1  mg  kg−1 IV  was  given  to  facilitate  tracheal  intubation.
The  dose  of  dexmedetomidine  was  based  on  a  literature21
hat  compared  dexmedetomidine-based  versus  fentanyl-
ased  TIVA  and  found  no  difference  in  extubation  and
o
w
r; C, ‘Infusion 2’ was stopped after gallbladder extraction; D, End
ischarge  times.  The  dose  of  remifentanil  was  based  on
tudies,  achieving  sufﬁcient  analgesia  for  LC.22,23
Dexmedetomidine  and  lidocaine  infusions  in  Group  DL  or
emifentanil  and  normal  saline  infusions  in  Group  RF  keep
onstant  during  surgery.  Propofol  infusion  rate  was  adjusted
o  3--12  mg  kg−1 h−1 to  maintain  the  mean  arterial  pressure
MAP)  within  ±20%  of  the  baseline  value,  and  to  maintain  a
IS  reading  below  50.  The  lidocaine  or  normal  saline  admin-
stration  was  terminated  after  gallbladder  extraction  or
proximately10  min  before  the  end  of  surgery.  Skin  incisions
ere  inﬁltrated  with  15--20  mL  of  bupivacaine  0.5%  includ-
ng  1/80.000  adrenaline  before  closure.  Dexmedetomidine
r  remifentanil  and  propofol  infusions  were  terminated
uring  skin  closure.  Residual  neuromuscular  blockade  was
ntagonized  with  neostigmine  0.05  mg  kg−1 and  atropine
.02  mg  kg−1 and  tracheal  extubation  was  performed  when
atients  achieved  a  regular  spontaneous  breathing  pattern.
The  lungs  were  mechanically  ventilated  with  a  mixture
f  oxygen  in  air  (FiO2:  50%,  tidal  volume  7--10  mL  kg−1,
espiratory  rate  10--14  min−1) to  obtain  an  end-tidal  car-
on  dioxide  (EtCO2)  value  between  30  and  35  mm  Hg.
upplemental  neuromuscular  blockade  was  achieved  with
ecuronium  after  assessment  of  neuromuscular  function
ith  train-of-four.  Intraoperative  normothermia  was  main-
ained  with  forced  air  warming  blankets  positioned  over  the
xposed  parts  of  the  body  and  IV  crystalloid  was  adminis-
ered  at  a  rate  of  6--12  mL  kg−1 h−1 during  anesthesia.  All
atients  wore  anti-embolic  stockings  and  received  enoxa-
arin  40  mg  subcutaneously  before  surgery;  dexamethasone
 mg  and  dexketoprophen  trometamol  50  mg  IV  after  anes-
hesia  induction;  and  paracetamol  1  g  IV  after  gallbladder
xtraction.Non-invasive  blood  pressure  was  assessed  at  least  at  3  min
f  interval  during  anesthesia.  Hypotension  (MAP  <  60  mm  Hg)
as  treated  with  ephedrine  10  mg  IV  and  bradycardia  (heart
ate  <  45  bpm)  was  treated  with  atropine  0.5--1  mg  IV.  A  bolus
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IV  dose  of  0.1  mg  nitroglycerine  was  administered  when
MAP  >  120  mmHg.
Surgery
Surgeons  who  were  experienced  in  laparoscopic  cholecys-
tectomy  performed  the  operations  using  standard  4-trocar
technique.  After  endotracheal  intubation  a  nasogastric
tube  was  inserted  and  stomach  content  was  aspirated.  A
blunt-tipped  12-mm  trocar  was  used  to  access  the  perit-
oneal  cavity.  Pneumoperitoneum  was  achieved  with  carbon
dioxide,  and  intra-abdominal  pressure  was  maintained  at
12--14  mm  Hg  throughout  surgery.  Three  additional  5-mm
ports  were  introduced  and  patients  were  positioned  in  30
degrees  anti-Trendelenburg  position  and  rotated  toward  the
left  side  to  facilitate  exposure  of  the  gallbladder.  At  the  end
of  surgery,  patients  were  returned  to  supine  position  and  the
inﬂated  carbon  dioxide  was  carefully  evacuated  by  manual
compression  of  the  abdomen.
Postoperative  care
A  PCA  pump  was  ready  to  use  immediately  after  extuba-
tion  for  6  h.  The  PCA  pump  was  set  to  deliver  fentanyl  IV
with  a  bolus  dose  of  20  g,  a  lockout  of  5  min,  without  con-
tinuous  infusion  and  dose  limit.  Transition  from  PACU  to
surgical  ward  was  considered  to  be  safe  when  the  patient
had  achieved  a  Modiﬁed  Aldrete  Score  ≥9.  Although  LC
is  established  as  a  day-case  procedure,  our  protocol  was
designed  to  admit  all  patients  for  24  h  to  ensure  adequate
follow-up  of  patients  and  for  proper  data  collection.  Patients
were  allowed  to  drink  water  4  h  after  extubation.  Postopera-
tive  nausea  and  vomiting  was  treated  with  metoclopramide
10  mg  IV  (with  8  h  of  time  interval)  and  if  not  effective  in
15  min  ondansetron  4  mg  IV  was  administered.  After  PCA
was  stopped  all  patients  received  oral  doses  of  paraceta-
mol  500  mg  (4  ×  1)  and  dexketoprophen  trometamol  25  mg
(3  ×  1)  and  tramadol  100  mg  as  a  rescue  analgesic.  Investi-
gators  blinded  to  treatment  allocation  and  with  no  access
to  the  intraoperative  records  performed  all  outcome  assess-
ments  in  the  post-anesthesia  care  unit  (PACU)  and  surgical
ward.  Pain  scores  were  assessed  using  the  11-point  NRS  (0
corresponding  to  no  pain  and  10  to  the  worst  imaginable
pain).
The  following  data  were  collected:  demographic  charac-
teristics  of  the  patients  studied,  history  of  smoking,  motion
sickness  and  PONV,  duration  of  surgery  and  anesthesia,
amount  of  drugs  used  during  surgery,  amount  of  fentanyl
used  in  postoperative  period  for  6  h,  NRS,  incidence  of  PONV
and  other  adverse  events.
Statistical  analysis
The  primary  outcome  variable  was  fentanyl  consumption
used  for  pain  relief  in  the  ﬁrst  6  h  after  extubation.
Secondary  outcome  measures  were  recovery  times,  the
incidence  of  PONV,  and  maximal  overall  NRS  pain  score
(max-NRS)  at  the  surgical  ward  after  PCA  was  discontin-
ued.  The  sample  size  requirement  was  based  on  preliminary
data  from  a  previous  pilot  study  with  ten  patients  in  which
t
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entanyl  requirements  were  200  ±  152  g  in  Group  RF  and
20  ±  88  g  in  Group  DL.  Thus,  at  an  alpha  risk  of  0.05,  39
atients  per  group  would  provide  80%  power  and  detect  a
0%  reduction  in  fentanyl  consumption  in  a  treatment  group.
he  results  are  presented  as  medians  and  quartiles.  Descrip-
ive  variables  are  given  as  percentages.  The  Mann--Whitney
 test  was  used  to  compare  the  continuous  parameters.
isher’s  exact  test  was  used  to  compare  non-parametric
ariables.  All  statistical  analyses  were  performed  using  the
ommercially  available  SPSS  v.16.0  software  package  (SPSS
nc.,  Chicago,  IL,  USA).  A  probability  value  of  less  than  0.05
as  considered  statistically  signiﬁcant.
esults
f  the  197  patient  approached,  66  did  not  meet  the  criteria
or  inclusion,  14  refused  to  participate  in  the  study,  4  turned
o  open  surgery,  leaving  80  patients  suitable  to  be  enrolled
n  this  investigation  (Fig.  1).
The  patients’  characteristics  and  perioperative  data  are
etailed  in  Table  2.  Patient  characteristics  were  not  sig-
iﬁcantly  different  among  groups.  Propofol  consumption,
rientation  and  PACU  discharge  times  were  signiﬁcantly
igher  in  Group  DL.
Baseline  values  of  heart  rate  and  mean  arterial  pressure
ere  comparable  between  the  groups.  Heart  rate  and  mean
rterial  pressure  values  after  induction,  at  intubation  and
st,  4th,  7th  and  10th  min  of  pneumoperitoneum  were  signiﬁ-
antly  higher  in  Group  DL  (Fig.  2).  There  were  more  patients
equiring  ephedrine  to  treat  hypotension  in  Group  RF,  and
ore  patients  requiring  nitroglycerine  to  treat  hyperten-
ion  in  Group  DL.  Nitroglycerine  use  in  Group  DL  (n  =  11)  was
ostly  at  the  beginning  of  the  pneumoperitoneum  (n  =  9).
ther  side  effects  were  comparable  among  groups,  except
ndansetron  use  (Table  3).  None  of  the  patients  in  Group
L  require  ondansetron  to  treat  PONV  (p  <  0.05).  None  of
he  patients  in  both  groups  reported  recall  of  intraoperative
vents  and  complained  about  any  side  effects  that  may  be
elated  to  lidocaine  (cardiac  arrhythmia,  perioral  numbness,
etal  taste,  tinnitus  and  visual  disturbances).
Three  patients  in  Group  RF  and  6  patients  in  Group  DL
ith  minimal  pain  preferred  not  to  use  PCA  (0  >  0.05).  Post-
perative  fentanyl  consumption  2  h  after  extubation  and
ax-NRS  and  rescue  analgesic  need  after  cessation  of  fen-
anyl  PCA  was  signiﬁcantly  lower  in  Group  DL  (Table  4).
umulative  postoperative  fentanyl  consumption  4  and  6 h
fter  extubation  were  comparable  among  groups  (Fig.  3).
iscussion
he  results  of  this  study  indicate  that  opioid-free  TIVA  with
exmedetomidine,  lidocaine  and  propofol  infusions  when
ompared  with  opioid-based  TIVA  with  remifentanil  and
ropofol  infusions,  is  associated  with  lower  fentanyl  require-
ents  in  the  early  postoperative  period  (0--2  h)  after  LC.
rolonged  analgesic  effect  of  dexmedetomidine  may  explain
his  ﬁnding,  but  total  dexmedetomidine  consumption  in
roup  DL  was  <1  g  kg−1 in  most  cases  and  patients  in  Group
F  had  preoperative  fentanyl  administration  which  might
ave  also  prolonged  analgesic  effect.  So,  opioid-induced
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Table  2  Demographic  Characteristics  and  Perioperative  Data.
Group  RF
n =  40
Group  DL
n =  40
P
Male/female  13/27  12/28  NS
Age (yr)  43.8  ±  9.3  43.1  ±  10.6  NS
Weight (kg)  79.2  ±  14.4  74.2  ±  14.7  NS
Height (cm)  1.65  ±  0.08  1.65  ±  0.09  NS
Body mass  index  (kg  m−1)  28.9  ±  4.1  27.2  ±  3.9  NS
ASA I/II  31/9  34/6  NS
History of  smoking:  n  (%)  10  (25)  13  (33)  NS
History of  previous  PONV:  n  (%) 4  (10) 7  (18) NS
History of  motion  sickness:  n  (%) 1  (2.5) 1  (2.5) NS
Duration of  surgery  (min) 57.5  (45.2--68.8) 50.5  (41.2--68) NS
Duration of  anesthesia  (min)  70  (57.8--79.5)  64.5  (51--81.2)  NS
Propofol doses  for  maintenance  (mg  kg−1 h−1)  5.18  ±  1.15  6.23  ±  1.47  0.003
Remifentanil  consumption  (g)  1430  ±  592  --  --
Dexmedetomidine  consumption  (g)  --  71  ±  19  --
Lidocaine consumption  (mg)  --  256  ±  90  --
Extubation time  (min)  9  (7--12.8)  10  (7--16)  NS
Orientation  time  (min)  13  (10--15.8)  14  (12--21)  0.045
PACU discharge  time  (min)  10  (10--15)  15  (10--20)  <0.001
Data are presented as relative number of patients, mean ± standard deviation, median (25th--75th percentile), or absolute number
(percentage).
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yperalgesia  seems  to  be  more  reasonable  for  this  ﬁnding.
umulative  fentanyl  consumption  becomes  comparable  at
th  and  6th  hours  postoperatively.  This  might  be  due  to  the
reatment  of  postoperative  pain  with  another  potent  opioid
fentanyl)  that  might  cause  hyperalgesia  and/or  tolerance.
f  we  could  make  the  postoperative  pain  treatment  opioid-
ree,  the  analgesic  consumption  in  Group  DL  might  continue
o  be  signiﬁcantly  lower  at  4th  and  6th  h  postoperatively.
hus,  the  max-NRS  scores  and  rescue  analgesic  need  after
essation  of  fentanyl  PCA  was  signiﬁcantly  lower  in  Group
L.
Potent  opioids  are  usually  have  to  be  used  to  con-
rol  the  intraoperative  cardiovascular  instability  due  to
neumoperitoneum  in  LC.24 It  has  been  reported  that  in
atients  undergoing  LC,  intraoperative  infusion  of  lidocaine,
80
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igure  2  Changes  in  heart  rate  between  groups  during  intra-
perative  periods.  0:  baseline  values,  BI:  before  intubation
after induction),  AI:  after  intubation,  P1:  1st  minute  of  pneu-
operitoneum,  P4:  4th  minute  of  pneumoperitoneum,  P7:  7th
inute  of  pneumoperitoneum,  P10:  10th  minute  of  pneumoperi-
oneum.  *:  p  <  0.05  between  groups
i
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p postoperative nausea and vomiting; PACU, post-anesthesia care
n  combination  with  low  doses  of  opioids  was  associ-
ted  with  reduced  intraoperative  and  postoperative  opioid
equirements.18,19 Park  et  al.25 reported  that  pain  scores
fter  LC  were  reduced  in  the  early  postoperative  period
y  the  addition  of  dexmedetomidine  in  the  multimodal
nalgesic  regimen.  Dexmedetomidine  has  mild  analgesic
roperties  than  opioids  have;  it  has  been  used  as  an  opi-
id  substitute  in  various  surgical  interventions21,26--28 and  is
ound  to  be  associated  with  less  postoperative  pain21,27 and
ONV21,27,28 but  slow  recovery.26,27 Also,  dexmedetomidine
se  (with  some  fentanyl  support)  as  a  remifentanil  substitute
n  TIVA  during  gynecologic  video-laparoscopic  surgery  was
ound  to  be  effective.29 But,  laparoscopic  cholecystectomy
s  unique  compared  with  other  laparoscopic  procedures  and
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igure  3  Changes  in  mean  arterial  pressure  between  groups
uring intraoperative  periods.  0:  baseline  values,  BI:  before
ntubation  (after  induction),  AI:  after  intubation,  P1:  1st  minute
f pneumoperitoneum,  P4:  4th  minute  of  pneumoperitoneum,
7: 7th  minute  of  pneumoperitoneum,  P10:  10th  minute  of
neumoperitoneum.  *:  p  <  0.05  between  groups
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Table  3  Incidence  of  events  and  side  effects.
Group  RF
n =  40
Group  DL
n =  40
P  value
Ephedrine  use  8  (20)  1  (3)  0.029
Nitroglycerine  use  0  11  (28)  <  0.001
Intraoperative  bradycardia  4  (10)  0  NS
Intraoperative  tachycardia  0  1  (3)  NS
Sub-hepatic  drain  use  6  (15)  5  (13)  NS
Shivering 10  (25)  3  (8)  NS
Nausea 13  (33)  5  (13)  NS
Vomiting 5 (13) 1  (3) NS
Ondansetron  use 6  (15) 0  0.026
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NS, not signiﬁcant.
associated  with  higher  sympathoadrenal  response,  so  we
want  to  increase  the  analgesic  effects  of  dexmedetomidine
and  lidocaine  by  combining  these  agents.
It  has  been  demonstrated  that  dexmedetomidine
enhances  the  local  anesthetic  action  of  lidocaine  in  pigs30
and  improves  the  quality  of  anesthesia  and  periopera-
tive  analgesia  when  added  to  lidocaine  for  IV  regional
anesthesia.31 Dexmedetomidine  use,  combined  with  lido-
caine  and  propofol  was  deﬁned  for  tracheal  intubation
without  the  use  of  muscle  relaxants  and  intubation  con-
ditions  were  found  to  be  statistically  more  satisfactory
compared  with  fentanyl.32 But,  the  combined  analgesic
effect  of  dexmedetomidine  and  lidocaine  in  total  intra-
venous  general  anesthesia  was  not  evaluated  before  our
study.
Previous  studies  in  patients  undergoing  LC  showed  that
intraoperative  esmolol  infusion  instead  of  opioids  is  associ-
ated  with  reduced  postoperative  opioid  requirements.5,6 In
a  similar  study  with  ours,  Collard  et  al.5 compared  fentanyl,
remifentanil  and  esmolol  adjunct  to  desﬂurane  anesthesia
for  LC  and  patients  in  esmolol  group  used  100  g  (median)
fentanyl  in  the  postoperative  period  (2  h),  which  seems
comparable  with  our  opioid-based  group.  In  our  study,  we
used  propofol  infusion  instead  of  desﬂurane  and  that  was
found  to  be  associated  with  less  postoperative  analgesic  con-
sumption  during  remifentanil-based  anesthesia.22,33 Also,
propofol  has  anti-emetic  properties.  Propofol  use  instead
r
p
t
Table  4  Postoperative  pain  intensity  analysis.
Group  RF
n =  40
Postoperative  fentanyl  consumption
0--2  h  (g)  120  ±  94  (110)  
0--4 h  (g)  185  ±  143  (160)  
0--6 h  (g)  235  ±  175  (220)  
Max-NRS 4  (2--6)  
Max-NRS-cough  5.5  (3--7)  
Shoulder pain  (n)  7  (18%)  
Rescue analgesic  need  (n)  19  (48%)  
Data are presented as mean ± standard deviation (median), median (25t
NS, not signiﬁcant, Max-NRS, maximal numeric rating scale score for pf  inhalational  anesthetics  in  LC  seems  more  suitable  in
his  opioid-free  concept.  But,  it  has  been  suggested  that
exmedetomidine  may  delay  recovery,  as  an  adjuvant  to
ropofol  during  TIVA.34 This  is  consistent  with  our  study,
hile  the  orientation  and  PACU  discharge  time  was  sig-
iﬁcantly  higher  in  Group  DL.  This  may  be  due  to  the
igher  infusion  rate  of  propofol  to  control  the  hemodynamic
esponse  to  pneumoperitoneum.
The  double-blind  fashion  of  the  study  may  be  a limitation;
s  the  infusion  rates  of  dexmedetomidine  and  remifentanil
ere  constant,  nitroglycerine  or  ephedrine  had  to  be  used
o  control  the  hemodynamic  ﬂuctuations  in  some  patients.
s  28%  of  patients  in  Group  DL  were  hypertensive  at  the
eginning  of  the  pneumoperitoneum  and  regarding  higher
itroglycerine  use  in  Group  DL,  the  protocol  can  be  mod-
ﬁed  with  addition  of  small  amount  of  opioid  or  a  higher
nfusion  rate  for  dexmedetomidine  (1  g  kg−1 loading  and
.2--0.5  g  kg−1 h−1 maintenance)  which  might  be  more  appro-
riate.  It  may  be  reasonable  to  prefer  delayed  recovery  to
ostoperative  increased  pain  intensity  and  PONV  for  some
atients.  Also,  desﬂurane  use  instead  of  propofol  (maximum
ose  was  limited  to  12  mg  kg−1 h−1)  in  Group  DL  might  alle-
iate  hypertensive  events  and  be  associated  with  shorter
ecovery.
Postoperative  pain  after  LC  is  highly  variable  among
atients.  There  is  need  for  individualized  anesthesia
echnique  and  postoperative  analgesic  treatment.  As
Group  DL
n =  40
p
75  ±  59  (60)  0.04
123  ±  100  (120)  NS
162  ±  142  (150)  NS
3  (2--4)  0.028
4  (3--5)  0.015
10  (25%)  NS
9  (23%)  0.034
h--75th percentile), or absolute number of patients (percentage).
ain intensity at the surgical ward after PCA was discontinued.
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exmedetomidine  and  lidocaine  decreases  the  anesthetic
nd  opioid  consumption,  it  is  reasonable  to  add  these  agents
n  an  anesthesia  regimen  for  LC.  Former  opioid  addiction  or
igh-risk  for  PONV  may  be  reasons  for  preference  of  this
pioid-free  technique.
In  conclusion:  when  compared  with  opioid-based  TIVA
ith  remifentanil  and  propofol  infusions,  opioid-free  TIVA
ith  dexmedetomidine,  lidocaine  and  propofol  infusions  is
ssociated  with  lower  fentanyl  requirements  in  the  early
ostoperative  period  (0--2  h).  Also,  max-NRS,  rescue  anal-
esic  need  and  ondansetron  use  was  signiﬁcantly  lower
n  the  opioid-free  group  in  the  ﬁrst  postoperative  day.
espite  prolonged  recovery  times,  opioid-free  anesthesia
ith  dexmedetomidine,  lidocaine  and  propofol  may  be  an
lternative  technique  for  LC  in  selected  patients  especially
ith  high  risk  of  PONV.
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